Chongqing Genrix Biopharmaceutical.
¥23.25
0
-¥0.29-1.23% Friday 06:56
Statistics
Day High
23.29
Day Low
23.25
52W High
36.08
52W Low
20.07
Volume
4,951
Avg. Volume
-
Mkt Cap
8.53B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30OctExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q1 2026
Next
-0.53
-0.52
-0.5
-0.49
Expected EPS
N/A
Actual EPS
N/A
Financials
-2,975.01%Profit Margin
Unprofitable53.6MRevenue
-1.59BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Chongqing Genrix Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China. It develops GR1501, a monoclonal antibody for the treatment of axial spondyloarthritis; GR1801, an anti-rabies virus G protein bispecific antibody; GR1802, an anti-IL-4Ra monoclonal antibody; GR1603, a monoclonal antibody for systemic lupus erythematosus; GR2002 an anti-TSLP bispecific antibody; WM1R3, a family receptor bispecific antibody; GR2001, a monoclonal antibody; GR2201, a monoclonal antibody for VZV infection; GR2302, a recombinant CD3xpMHC (HBV-S); GR2301, a recombinant anti-IL-15 monoclonal antibody; GR2304, a recombinant CD3xpMHC (PRAME); GR2502, a TCR-based antibody (TCRm); GR2603, a recombinant humanized trispecific antibody; GR1803, a bispecific antibody for multiple myeloma; GR1901, a bispecific antibody; WM202 a bispecific antibody; WM215, a single-domain antibody; GR1401, an anti-EGFR monoclonal antibody; and GR1405 an anti-PD-L1 monoclonal antibody. The company was founded in 2015 and is based in Chongqing, China.
Show more...
CEO
Mr. Zhigang Liu
Employees
984
Country
China
ISIN
CNE100006KG8
Listings
0 Comments
Share your thoughts
FAQ
What is Chongqing Genrix Biopharmaceutical. stock price today?▼
The current price of 688443.SHG is ¥23.25 CNY — it has decreased by -1.23% in the past 24 hours. Watch Chongqing Genrix Biopharmaceutical. stock price performance more closely on the chart.
What is Chongqing Genrix Biopharmaceutical. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Shanghai Stock Exchange exchange Chongqing Genrix Biopharmaceutical. stocks are traded under the ticker 688443.SHG.
Is Chongqing Genrix Biopharmaceutical. stock price growing?▼
688443.SHG stock has fallen by -4% compared to the previous week, the month change is a -0.73% fall, over the last year Chongqing Genrix Biopharmaceutical. has showed a -32.61% decrease.
What is Chongqing Genrix Biopharmaceutical. market cap?▼
Today Chongqing Genrix Biopharmaceutical. has the market capitalization of 8.53B
When is the next Chongqing Genrix Biopharmaceutical. earnings date?▼
Chongqing Genrix Biopharmaceutical. is going to release the next earnings report on October 30, 2026.
What is Chongqing Genrix Biopharmaceutical. revenue for the last year?▼
Chongqing Genrix Biopharmaceutical. revenue for the last year amounts to 53.6M CNY.
What is Chongqing Genrix Biopharmaceutical. net income for the last year?▼
688443.SHG net income for the last year is -1.59B CNY.
How many employees does Chongqing Genrix Biopharmaceutical. have?▼
As of September 05, 2026, the company has 984 employees.
In which sector is Chongqing Genrix Biopharmaceutical. located?▼
Chongqing Genrix Biopharmaceutical. operates in the Other sector.
When did Chongqing Genrix Biopharmaceutical. complete a stock split?▼
Chongqing Genrix Biopharmaceutical. has not had any recent stock splits.
Where is Chongqing Genrix Biopharmaceutical. headquartered?▼
Chongqing Genrix Biopharmaceutical. is headquartered in Chongqing, China.